Page last updated: 2024-12-08

docosahexaenoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

efalex: a mixture of fish oil and primrose oil; used as a high-docosahexaenoic acid fatty acid supplement [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

docosahexaenoic acid : Any C22 polyunsaturated fatty acid containing six double bonds. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

docosahexaenoate : A polyunsaturated fatty acid anion that is the conjugate base of docosahexaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

all-cis-docosa-4,7,10,13,16,19-hexaenoic acid : A docosahexaenoic acid having six cis-double bonds at positions 4, 7, 10, 13, 16 and 19. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID445580
CHEMBL ID367149
CHEBI ID28125
CHEBI ID36005
SCHEMBL ID19577
MeSH IDM0006700

Synonyms (140)

Synonym
AC-1010
BRD-K39965020-001-02-6
gtpl1051
retriacyl (proposed trade name)
all-cis-4,7,10,13,16,19-docosahexaenoic acid
cervonic acid
doconexent
all-cis-dha
docosa-4,7,10,13,16,19-hexaenoic acid
22:6(n-3)
CHEBI:28125 ,
all-cis-docosa-4,7,10,13,16,19-hexaenoic acid
SPECTRUM5_002062
IDI1_033768
BSPBIO_001298
BCBCMAP01_000145
docosahexaenoic acid (6ci)
4,7,10,13,16,19-docosahexaenoic acid, (all-z)- (8ci)
delta4,7,10,13,16,19-docosahexaenoic acid
4,7,10,13,16,19-docosahexaenoic acid, (all-z)-
4,7,10,13,16,19-docosahexaenoic acid, (4z,7z,10z,13z,16z,19z)- (9ci)
docosahexaenoic acid (all-z)
(4z,7z,10z,13z,16z,19z)-4,7,10,13,16,19-docosahexaenoic acid
4-cis,7-cis,10-cis,13-cis,16-cis,19-cis-docosahexaenoic acid
(all-z)-4,7,10,13,16,19-docosahexaenoic acid
all-z-docosahexaenoic acid
ccris 7670
cis-4,7,10,13,16,19-docosahexaenoic acid
docosahexaenoic acid
docosahexaenoate
(4z,7z,10z,13z,16z,19z)-docosa-4,7,10,13,16,19-hexaenoic acid
4z,7z,10z,13z,16z,19z-docosahexaenoic acid
C06429
(4z,7z,10z,13z,16z,19z)-docosahexaenoic acid
cis-4,7,10,13,16,19-docosahexaenoic acid, >=98%
DB03756
1FDQ
LMFA01030185
c22:6n-3,6,9,12,15,18
NCGC00161345-03
NCGC00161345-01
NCGC00161345-02
NCGC00161345-05
NCGC00161345-04
dtxsid5040465 ,
fa 22:6
HMS1989A20
800E8E72-BBF4-46F7-A60B-B8F2B54669C7
efalex
BML3-B02
docosahexaenoic acid (22:6 n-3)
HMS1361A20
HMS1791A20
docosaheaenoic-acid
docosahexanoic acid
CHEMBL367149 ,
22:6 n-3
omega-3 marine triglycerides
docosahexaenoic acid (c22:6 n3)
c22:6 (n-3)
bdbm50210259
D2226
dtxcid3020465
cas-6217-54-5
tox21_111992
z,z,z,z,z,z-docosa-4,7,10,13,16,19-hexaenoic acid
(4z,7z,10z,13z,16z,19z)-docosa-4,7,10,13,16,19- hexaenoic acid
(4z,7z,10z,13z,16z,19z)-docosa-4, 7,10,13,16,19-hexaenoic acid
(4z,7z,10z,13z,16z, 19z)-docosa-4,7,10,13,16,19-hexaenoic acid
all cis- docosahexaenoic acid (cis-dha)
MLS004773950
smr001881493
docosahexaenoic acid(dha)
AKOS015962159
martek dha hm
monolife 50
unii-zad9okh9jc
aquagrow advantage
ropufa 60
zad9okh9jc ,
doconexentum [inn-latin]
marinol d 50tg
doconexento [inn-spanish]
doxonexent
doconexento
doconexentum
doconexent [inn]
docosahexaenoic acid [vandf]
docosahexaenoic acid [mi]
docosahexaenoic acid [mart.]
25377-50-8
docosahexaenoic acid [who-dd]
docosahexaenoic acid (dha) (c22:6 n3)
docosahexaenoic acid [inci]
docosahexaenoic acid [usp-rs]
CCG-207958
CCG-208135
SCHEMBL19577
4,7,10,13,16,19-docosahexaenoic acid, (all cis)-
cis-4,7,10,13,16,19-docosahexanoic acid
HMS3649J15
HMS3402A20
KL-0761
AB01563379_01
cis-4,7,13,16,19-docosahexaenoic acid (stabilized with vitamine e)
SR-05000002130-1
sr-05000002130
cis-4,7,10,13,16,19-docosahexaenoic acid, analytical standard
cis-4,7,10,13,16,19-docosahexaenoic acid, 500 mug/ml in ethanol, certified reference material
cis-4,7,10,13,16,19-docosahexanoate
all-z-docosahexaenoate
cervonate
H10987
algal dha
A320050000 ,
CS-6261
HY-B2167
Q423345
c22h32o2 (cis-4,7,10,13,16,19-docosahexaenoic acid)
1024594-51-1
4,7,10,13,16,19-docosahexaenoate
SR-05000002130-4
dha-[21,21,22,22,22-d5]
NCGC00161345-07
docosa-4z,7z,10z,13z,16z,19z-hexaenoic acid (22:6, n-3)
S6454
fa(22:6(4z,7z,10z,13z,16z,19z))
docosahexanenoic acid
docohexanenoic acid
obtrex dha combo pack
select-ob plus dhaprenatal supplement plus dha
obstetrix dha combo pack
complete natal dha
wesnatal dha complete
vitafol-ob plus dhaprenatal supplement plus dha
doconexentum (inn-latin)
doconexento (inn-spanish)
DTXSID401018161 ,
BP-29833
chebi:36005

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" A potent, orally bioavailable small molecule GPR40 agonist is hypothesized to be an effective antidiabetic posing little or no risk of hypoglycemia."( Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist.
Brown, SP; Dransfield, PJ; Guo, Q; Houze, JB; Jiao, X; Li, F; Lin, DC; Liu, J; Luo, J; Medina, JC; Pattaropong, V; Sun, Y; Swaminath, G; Vimolratana, M; Wong, S; Zhang, J; Zhu, L; Zhuang, R, 2012
)
0.38
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (70 Product(s))

Product Categories

Product CategoryProducts
Pet Supplies39
Professional Supplements6
Vitamins & Supplements24
Active Lifestyle & Fitness1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Abound Dog Training Soft Treats Beef -- 11 ozAboundPet SuppliesDocosahexaenoic Acid2024-11-29 10:47:42
Abound Dog Training Soft Treats Chicken -- 11 ozAboundPet SuppliesDocosahexaenoic Acid2024-11-29 10:47:42
Abound Dry Dog Food Wild Beginnings Beef Venison & Lamb -- 4 lbsAboundPet SuppliesVitamin E, Docosahexaenoic Acid, Vitamin E, L-Carnitine, Phosphorus, Vitamin A, Selenium, Taurine2024-11-29 10:47:42
Abound Dry Dog Food Wild Beginnings Salmon Whitefish & Trout -- 4 lbsAboundPet SuppliesVitamin E, Docosahexaenoic Acid, Vitamin E, L-Carnitine, Phosphorus, Vitamin A, Selenium, Taurine2024-11-29 10:47:42
Abound Pro Dry Dog Food Vet Formulated Senior Salmon Pea -- 8 lbsAboundPet SuppliesVitamin C, Chondroitin, Vitamin E, Docosahexaenoic Acid, Vitamin E, Glucosamine, L-Carnitine, Phosphorus2024-11-29 10:47:42
Abound Pro Dry Dog Food Vet Formulated Skin & Coat Salmon Brown Rice -- 8 lbsAboundPet SuppliesVitamin C, Vitamin E, Docosahexaenoic Acid, Vitamin E, Linoleic Acid, Phosphorus, Selenium2024-11-29 10:47:42
Abound Pro Wet Puppy Food Vet Formulated Chicken Vegetable Stew -- 13.2 ozAboundPet SuppliesVitamin E, Docosahexaenoic Acid, Vitamin E, L-Carnitine2024-11-29 10:47:42
Allergy Research Group Super EPA Fish Oil Concentrate -- 200 SoftgelsAllergy Research GroupProfessional SupplementsVitamin E, Docosahexaenoic Acid, Vitamin E2024-11-29 10:47:42
Amazing Nutrition Amazing Omega Norwegian Cod Liver Oil Fresh Lemon -- 1250 mg - 120 SoftgelsAmazing NutritionVitamins & SupplementsDocosahexaenoic Acid, Vitamin A2024-11-29 10:47:42
Ancient Nutrition Omegas Whole Body -- 1000 mg - 90 SoftgelsAncient NutritionVitamins & SupplementsAlpha-Linolenic Acid, Astaxanthin, Docosahexaenoic Acid2024-11-29 10:47:42
Animal Advanced Omega -- 30 PacksAnimalActive Lifestyle & FitnessAlpha-Linolenic Acid, Vitamin E, Docosahexaenoic Acid, Gamma Linolenic Acid, Vitamin E2024-11-29 10:47:42
Bark & Whiskers Wild Alaskan Cod Liver Oil Vet Formulated for Dogs & Cats -- 6.8 fl ozBark & WhiskersPet SuppliesVitamin E, Docosahexaenoic Acid, Vitamin E, Vitamin A2024-11-29 10:47:42
Country Life Ultra Concentrated Omega™ 3 6 9 -- 90 SoftgelsCountry LifeVitamins & SupplementsAlpha-Linolenic Acid, Vitamin E, Docosahexaenoic Acid, Vitamin E, Linoleic Acid, Oleic Acid2024-11-29 10:47:42
DaVinci Laboratories Omega-3 1000™ -- 90 Enteric Coated SoftgelsDaVinci LaboratoriesProfessional SupplementsVitamin E, Docosahexaenoic Acid, Vitamin E2024-11-29 10:47:42
Deva Vegan Omega-3 DHA from Algae Lemon -- 2 fl ozDevaVitamins & SupplementsVitamin E, Docosahexaenoic Acid, Vitamin E2024-11-29 10:47:42
Dr. Goodpet Bena Fish Oil™ for Pets -- 45 SoftgelsDr. GoodpetPet SuppliesVitamin E, Docosahexaenoic Acid, Vitamin E, Fat2024-11-29 10:47:42
Dr. Mercola Antarctic Krill Oil -- 180 CapsulesDr. MercolaProfessional SupplementsDocosahexaenoic Acid2024-11-29 10:47:42
Dr. Mercola Antarctic Krill Oil -- 60 CapsulesDr. MercolaProfessional SupplementsDocosahexaenoic Acid2024-11-29 10:47:42
Earthborn Holistic Coastal Catch Dry Dog Food Sensitive Skin & Stomach -- 4 lbsEarthborn HolisticPet SuppliesDocosahexaenoic Acid2024-11-29 10:47:42
Earthborn Holistic Unrefined Dry Dog Food with Ancient Grains Roasted Rabbit -- 4 lbsEarthborn HolisticPet SuppliesAscorbic Acid, Docosahexaenoic Acid2024-11-29 10:47:42
Earthborn Holistic Unrefined Dry Dog Food with Ancient Grains Smoked Salmon -- 4 lbsEarthborn HolisticPet SuppliesAscorbic Acid, Docosahexaenoic Acid2024-11-29 10:47:42
Get Naked Cat Health Cranberry Crunchy Treats Grain-Free -- 2.5 ozGet NakedPet SuppliesDocosahexaenoic Acid2024-11-29 10:47:42
Get Naked Biteables Functional Kitten Soft Treats Kitten Health Chicken & Seafood Recipe -- 3 ozGet NakedPet SuppliesDocosahexaenoic Acid2024-11-29 10:47:42
Get Naked Dental Sticks Dog Treats Puppy Health Brain Chicken 19 Sticks -- 6.2 ozGet NakedPet SuppliesDocosahexaenoic Acid2024-11-29 10:47:42
Get Naked Kitten Health Cognitive Development Natural Soft Treat Chicken Flavor -- 2.5 ozGet NakedPet SuppliesDocosahexaenoic Acid2024-11-29 10:47:42
Get Naked Natural Dental Stick Adult Dog Treats Skin & Coat Health 6.2 oz Chicken Flavor - SmallGet NakedPet SuppliesDocosahexaenoic Acid2024-11-29 10:47:42
Get Naked Natural Dental Stick Adult Dog Treats Skin & Coat Health 6.6 oz Chicken Flavor - LargeGet NakedPet SuppliesDocosahexaenoic Acid2024-11-29 10:47:42
Halo Senior Dog Wet Food Grain-Free Chicken Recipe -- 13.2 oz Each / Pack of 6HaloPet Suppliesbiotin, D-calcium pantothenate, choline chloride, Docosahexaenoic Acid, folic acid, potassium chloride, potassium iodide, pyridoxine hydrochloride, sodium carbonate, sodium selenite2024-11-29 10:47:42
Halo Wet Kitten Food Grain-Free Chicken Recipe -- 3 oz Each / Pack of 12HaloPet Suppliesbiotin, calcium pantothenate, choline chloride, Docosahexaenoic Acid, potassium chloride, pyridoxine hydrochloride, sodium selenite, taurine, tricalcium phosphate2024-11-29 10:47:42
Halo Wet Kitten Food Grain-Free Whitefish Recipe -- 3 oz Each / Pack of 12HaloPet Suppliesbiotin, D-calcium pantothenate, choline chloride, Docosahexaenoic Acid, magnesium sulfate, potassium chloride, potassium iodide, pyridoxine hydrochloride, sodium selenite, taurine2024-11-29 10:47:42
Havasu Nutrition Omega3 6 9 + DHA Gummies -- 60 GummiesHavasu NutritionVitamins & SupplementsVitamin C, Omega-3, Docosahexaenoic Acid, malic acid, sodium citrate, sugar2024-11-29 10:47:42
I and Love and You Naked Essentials Puppy Dry Dog Food Chicken + Lentils -- 4 lbsI and Love and YouPet Suppliesd-calcium pantothenate, choline chloride, copper sulfate, Vitamin E, Docosahexaenoic Acid, iron sulfate, folic acid, Vitamin E, niacin, Phosphorus, pyridoxine hydrochloride, Vitamin A, sodium selenite, Taurine, zinc sulfate2024-11-29 10:47:42
I and Love and You Nude Super Food Dry Dog Food Poultry Palooza -- 5 lbsI and Love and YouPet Suppliescitric acid, d-calcium pantothenate, citric acid, copper sulfate, Docosahexaenoic Acid, ferrous sulfate, folic acid, pyridoxine hydrochloride, sodium selenite, Taurine, zinc oxide2024-11-29 10:47:42
Integrative Therapeutics Pure Omega HP -- 120 SoftgelsIntegrative TherapeuticsProfessional SupplementsDocosahexaenoic Acid, glycerin2024-11-29 10:47:42
Integrative Therapeutics Pure Omega Ultra HP -- 90 SoftgelsIntegrative TherapeuticsProfessional SupplementsDocosahexaenoic Acid, glycerin2024-11-29 10:47:42
Jigsaw Health Alaskan Cod Liver Oil -- 180 SoftgelsJigsaw HealthVitamins & SupplementsDocosahexaenoic Acid, Docosapentaenoic Acid, glycerin, Vitamin A2024-11-29 10:47:42
N-Bone Dental Rings Adult Dog Treats - 7 Rings Chicken -- 9.8 ozN-BonePet Suppliescitric acid, citric acid, Docosahexaenoic Acid, powdered cellulose, calcium carbonate2024-11-29 10:47:42
N-Bone Dental Rings Senior Dog Treats - 7 Rings Chicken -- 9.8 ozN-BonePet Suppliescitric acid, citric acid, Docosahexaenoic Acid, calcium carbonate2024-11-29 10:47:42
N-Bone Puppy Teething Sticks Dog Treat Pumpkin -- 3.74 ozN-BonePet Suppliescitric acid, citric acid, Docosahexaenoic Acid, calcium carbonate2024-11-29 10:47:42
N-Bone Puppy Teething Sticks Dog Treats Chicken -- 3.74 ozN-BonePet Suppliescitric acid, citric acid, Docosahexaenoic Acid2024-11-29 10:47:42
N-Bone Puppy Teething Sticks Dog Treats Peanut Butter -- 3.74 ozN-BonePet Suppliescitric acid, citric acid, Docosahexaenoic Acid2024-11-29 10:47:42
N-Bone Puppy Teething Sticks Dog Treats Large Breed Puppy Chicken -- 7.28 ozN-BonePet Suppliescitric acid, citric acid, Docosahexaenoic Acid2024-11-29 10:47:42
Natural Dog Company Skin & Coat High Omega-3 Liquid Supplement Oil For Dogs -- 16 fl ozNatural Dog CompanyPet Suppliesascorbic acid, Vitamin E, Docosahexaenoic Acid, Vitamin E, sorbic acid2024-11-29 10:47:42
Natural Dog Company Skin and Coat Supplements For Dogs -- 90 Soft ChewsNatural Dog CompanyPet SuppliesAscorbic Acid, Vitamin E, Docosahexaenoic Acid, Vitamin E2024-11-29 10:47:42
Natural Dog Company Wild Alaskan Salmon Oil Liquid Supplement For Dogs -- 16 fl ozNatural Dog CompanyPet SuppliesDocosahexaenoic Acid2024-11-29 10:47:42
Natural Dog Company Wild Alaskan Salmon Oil Liquid Supplement For Dogs -- 32 fl ozNatural Dog CompanyPet SuppliesDocosahexaenoic Acid2024-11-29 10:47:42
Natural Factors OmegaFactors Wild Alaskan Salmon Oil -- 1000 mg - 180 SoftgelsNatural FactorsVitamins & SupplementsDocosahexaenoic Acid, glycerin2024-11-29 10:47:42
Natural Factors RX Omega-3 Ultra Strength -- 2150 mg - 150 SoftgelsNatural FactorsVitamins & SupplementsDocosahexaenoic Acid, Docosapentaenoic Acid, glycerin2024-11-29 10:47:42
Natural Stacks Brain Essentials Stacks -- 150 SoftgelsNatural StacksVitamins & SupplementsDocosahexaenoic Acid2024-11-29 10:47:42
NutraChamps Omega 3 Fish Oil Natural Lemon -- 180 SoftgelsNutraChampsVitamins & SupplementsDocosahexaenoic Acid, glycerol2024-11-29 10:47:42
Onnit Krill Oil -- 60 SoftgelsOnnitVitamins & SupplementsAstaxanthin, Docosahexaenoic Acid, ethyl vanillin2024-11-29 10:47:42
Sundown Naturals Complete Omega -- 90 SoftgelsSundown NaturalsVitamins & SupplementsDocosahexaenoic Acid2024-11-29 10:47:42
Sundown Naturals Triple Omega 3-6-9 VALUE SIZE -- 200 SoftgelsSundown NaturalsVitamins & SupplementsAlpha-Linolenic Acid, Docosahexaenoic Acid, Gamma Linolenic Acid, Linoleic Acid, Oleic Acid2024-11-29 10:47:42
Vitacost-Synergy Mega EFA + D3 1200 mg Omega-3 EPA & DHA - 50 mcg D3 per serving -- 240 SoftgelsVitacost-SynergyVitamins & Supplementscholecalciferol, Docosahexaenoic Acid, D32024-11-29 10:47:42
Vitacost-Synergy Mega EFA CoQ10 - 1200 mg Omega-3 EPA & DHA - 100 mg CoQ10 per serving -- 120 SoftgelsVitacost-SynergyVitamins & SupplementsCoenzyme Q10, Docosahexaenoic Acid2024-11-29 10:47:42
Vitacost-Synergy Mega EFA® Mini Gels - 1,200 mg Omega-3 EPA & DHA per serving -- 240 SoftgelsVitacost-SynergyVitamins & SupplementsDocosahexaenoic Acid, glycerin2024-11-29 10:47:42
Vitacost-Synergy Mega EFA® + CoQ10 - 1200 mg Omega-3 EPA & DHA with 100 mg CoQ10 per serving -- 60 SoftgelsVitacost-SynergyVitamins & SupplementsCoenzyme Q10, Docosahexaenoic Acid2024-11-29 10:47:42
Vitacost-Synergy Mega EFA® 1200 mg Omega-3 EPA & DHA -- 120 SoftgelsVitacost-SynergyVitamins & SupplementsDocosahexaenoic Acid, glycerin2024-11-29 10:47:42
Vitacost-Synergy Mega EFA® 1200 mg Omega-3 EPA & DHA per serving -- 240 SoftgelsVitacost-SynergyVitamins & SupplementsDocosahexaenoic Acid, glycerin2024-11-29 10:47:42
Vitacost-Synergy Mega EFA® 1200 mg Omega-3 EPA & DHA per serving -- 60 SoftgelsVitacost-SynergyVitamins & SupplementsDocosahexaenoic Acid, glycerin2024-11-29 10:47:42
Vitacost-Synergy Super DHA Omega-3 -- 1000 mg - 120 SoftgelsVitacost-SynergyVitamins & SupplementsDocosahexaenoic Acid2024-11-29 10:47:42
Vitacost-Synergy Super EPA Omega-3 -- 1200 mg - 120 SoftgelsVitacost-SynergyVitamins & SupplementsDocosahexaenoic Acid2024-11-29 10:47:42
Zahler Prenatal + DHA 300 Optimal Formula -- 120 SoftgelsZahlerVitamins & Supplementsannatto, Vitamin C, Biotin, Choline, Chromium, Vitamin E, Docosahexaenoic Acid, Folate, Vitamin E, glycerin, Iodine, Manganese, Molybdenum, Niacin, Pantothenic Acid, Vitamin B6, Vitamin A, Riboflavin, Selenium, Thiamin, Vitamin B12, Vitamin B6, Vitamin K2024-11-29 10:47:42
Zahler Prenatal + DHA 300 Optimal Formula -- 180 SoftgelsZahlerVitamins & SupplementsVitamin C, Biotin, Vitamin D3, Choline, Chromium, Vitamin E, Docosahexaenoic Acid, Riboflavin 5-Phosphate, Folate, Vitamin E, Iodine, Manganese, Vitamin K2, Vitamin K2, Molybdenum, Niacin, Pantothenic Acid, Vitamin B6, Vitamin A, Riboflavin, Selenium, Thiamin, Vitamin B12, Vitamin B6, Vitamin K12024-11-29 10:47:42
Zesty Paws 8-in-1 Multivitamin Bites Supplement for Dogs Chicken -- 250 Soft ChewsZesty PawsPet Suppliescitric acid, Vitamin C, Biotin, calcium pantothenate, citric acid, Vitamin E, Docosahexaenoic Acid, Folic Acid, vitamin E, powdered cellulose, Vitamin B3, Vitamin B5, Vitamin B6, Vitamin B2, Vitamin B1, vitamin B12, Vitamin B62024-11-29 10:47:42
Zesty Paws 8-in-1 Multivitamin Bites Supplement for Dogs Peanut Butter -- 90 Soft ChewsZesty PawsPet Suppliescitric acid, Vitamin C, Biotin, calcium pantothenate, citric acid, Vitamin E, Docosahexaenoic Acid, Folic Acid, vitamin E, powdered cellulose, manganese, Vitamin B3, Vitamin B5, Vitamin B6, Vitamin B2, Vitamin B1, vitamin B12, Vitamin B62024-11-29 10:47:42
Zesty Paws All-In-One Training Bites for Dogs Bacon -- 8 ozZesty PawsPet Suppliescitric acid, alpha-linolenic acid, citric acid, docosahexaenoic acid, linoleic acid, max2024-11-29 10:47:42
Zesty Paws All-In-One Training Bites for Dogs Peanut Butter -- 8 ozZesty PawsPet Suppliescitric acid, alpha-linolenic acid, citric acid, docosahexaenoic acid, linoleic acid, max2024-11-29 10:47:42
Zesty Paws Senior Advanced Vision Bites Supplement Dogs Chicken -- 90 Soft ChewsZesty PawsPet SuppliesVitamin C, Astaxanthin, Beta Carotene, Vitamin E, Docosahexaenoic Acid, Vitamin E, powdered cellulose, Lutein2024-11-29 10:47:42
Zesty Paws Skin & Coat Fish Oil & Omega-3 Supplement for Dogs Bacon -- 90 Soft ChewsZesty PawsPet SuppliesAscorbic Acid, Biotin, d-Alpha-Tocopherol, Docosahexaenoic Acid, vitamin E, sorbic acid2024-11-29 10:47:42

Roles (6)

RoleDescription
nutraceuticalA product in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
Daphnia tenebrosa metaboliteA Daphnia metabolite produced by the species Daphnia tenebrosa.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
algal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in algae including unicellular organisms like chlorella and diatoms to multicellular organisms like giant kelps and brown algae.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
omega-3 fatty acidA family of polyunsaturated fatty acids that have in common a final carbon-carbon double bond in the omega-3 position, i.e., the third bond from the methyl end of the fatty acid.
docosahexaenoic acidAny C22 polyunsaturated fatty acid containing six double bonds.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (7)

PathwayProteinsCompounds
Alpha Linolenic Acid and Linoleic Acid Metabolism517
Omega-3 / omega-6 fatty acid synthesis038
Mitochondrial beta-oxidation064
Elongation of (very) long chain fatty acids345
Folic acid network070
Selenium micronutrient network095
Omega-3 and omega-6 unsaturated fatty acids biosynthesis pathway014

Protein Targets (23)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
phosphopantetheinyl transferaseBacillus subtilisPotency79.43280.141337.9142100.0000AID1490
USP1 protein, partialHomo sapiens (human)Potency50.11870.031637.5844354.8130AID504865
GLS proteinHomo sapiens (human)Potency25.11890.35487.935539.8107AID624170
TDP1 proteinHomo sapiens (human)Potency27.35000.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency17.39600.180013.557439.8107AID1460; AID1468
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency28.19500.011212.4002100.0000AID1030
estrogen nuclear receptor alphaHomo sapiens (human)Potency21.31380.000229.305416,493.5996AID743075
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency11.67230.035520.977089.1251AID504332
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency34.82500.354828.065989.1251AID504847
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency33.49150.000323.4451159.6830AID743065; AID743067
gemininHomo sapiens (human)Potency33.49830.004611.374133.4983AID624296
DNA polymerase kappa isoform 1Homo sapiens (human)Potency10.00000.031622.3146100.0000AID588579
Inositol monophosphatase 1Rattus norvegicus (Norway rat)Potency31.62281.000010.475628.1838AID1457
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Prostaglandin G/H synthase 1 Bos taurus (cattle)IC50 (µMol)15.00000.00051.41288.2000AID360928
Cytochrome P450 1A2Homo sapiens (human)Ki6.29200.00561.15349.0000AID1615905
AromataseHomo sapiens (human)IC50 (µMol)33.20000.00001.290410.0000AID376617
Retinoic acid receptor RXR-alphaHomo sapiens (human)Ki6.29200.00040.56927.6320AID1615905
Caspase-1Homo sapiens (human)IC50 (µMol)6.76000.00201.70138.8000AID1801388
Prostaglandin G/H synthase 2Ovis aries (sheep)IC50 (µMol)9.80000.00101.453910.0000AID360927
Oxoeicosanoid receptor 1Homo sapiens (human)IC50 (µMol)2.00000.00301.41722.0000AID1067780
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, FATTY ACID-BINDING PROTEIN, BRAINHomo sapiens (human)Kd0.05340.04670.05000.0534AID977611
Chain A, Fatty Acid-binding Protein, BrainHomo sapiens (human)Kd0.05340.04670.05000.0534AID977611
Free fatty acid receptor 1Homo sapiens (human)EC50 (µMol)23.85000.00030.73698.8000AID1313430; AID692589
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Retinoic acid receptor RXR-alphaHomo sapiens (human)ED5050.00004.90004.90004.9000AID1180602
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (95)

Processvia Protein(s)Taxonomy
phospholipase C-activating G protein-coupled receptor signaling pathwayFree fatty acid receptor 1Homo sapiens (human)
positive regulation of cytosolic calcium ion concentrationFree fatty acid receptor 1Homo sapiens (human)
insulin secretionFree fatty acid receptor 1Homo sapiens (human)
negative regulation of interleukin-1 beta productionFree fatty acid receptor 1Homo sapiens (human)
glucose homeostasisFree fatty acid receptor 1Homo sapiens (human)
positive regulation of calcium ion transportFree fatty acid receptor 1Homo sapiens (human)
response to fatty acidFree fatty acid receptor 1Homo sapiens (human)
ion channel modulating, G protein-coupled receptor signaling pathwayFree fatty acid receptor 1Homo sapiens (human)
ligand-gated ion channel signaling pathwayFree fatty acid receptor 1Homo sapiens (human)
positive regulation of insulin secretionFree fatty acid receptor 1Homo sapiens (human)
G protein-coupled receptor signaling pathwayFree fatty acid receptor 1Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 1 Bos taurus (cattle)
cellular oxidant detoxificationProstaglandin G/H synthase 1 Bos taurus (cattle)
steroid catabolic processCytochrome P450 1A2Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A2Homo sapiens (human)
cholesterol metabolic processCytochrome P450 1A2Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A2Homo sapiens (human)
toxin biosynthetic processCytochrome P450 1A2Homo sapiens (human)
post-embryonic developmentCytochrome P450 1A2Homo sapiens (human)
alkaloid metabolic processCytochrome P450 1A2Homo sapiens (human)
regulation of gene expressionCytochrome P450 1A2Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 1A2Homo sapiens (human)
dibenzo-p-dioxin metabolic processCytochrome P450 1A2Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
lung developmentCytochrome P450 1A2Homo sapiens (human)
methylationCytochrome P450 1A2Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 1A2Homo sapiens (human)
retinol metabolic processCytochrome P450 1A2Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A2Homo sapiens (human)
cellular respirationCytochrome P450 1A2Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 1A2Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A2Homo sapiens (human)
oxidative demethylationCytochrome P450 1A2Homo sapiens (human)
cellular response to cadmium ionCytochrome P450 1A2Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
negative regulation of chronic inflammatory responseAromataseHomo sapiens (human)
steroid biosynthetic processAromataseHomo sapiens (human)
estrogen biosynthetic processAromataseHomo sapiens (human)
androgen catabolic processAromataseHomo sapiens (human)
syncytium formationAromataseHomo sapiens (human)
negative regulation of macrophage chemotaxisAromataseHomo sapiens (human)
sterol metabolic processAromataseHomo sapiens (human)
female genitalia developmentAromataseHomo sapiens (human)
mammary gland developmentAromataseHomo sapiens (human)
uterus developmentAromataseHomo sapiens (human)
prostate gland growthAromataseHomo sapiens (human)
testosterone biosynthetic processAromataseHomo sapiens (human)
positive regulation of estradiol secretionAromataseHomo sapiens (human)
female gonad developmentAromataseHomo sapiens (human)
response to estradiolAromataseHomo sapiens (human)
positive regulation of cholesterol effluxRetinoic acid receptor RXR-alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIRetinoic acid receptor RXR-alphaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIRetinoic acid receptor RXR-alphaHomo sapiens (human)
positive regulation of thyroid hormone mediated signaling pathwayRetinoic acid receptor RXR-alphaHomo sapiens (human)
hormone-mediated signaling pathwayRetinoic acid receptor RXR-alphaHomo sapiens (human)
positive regulation of bone mineralizationRetinoic acid receptor RXR-alphaHomo sapiens (human)
positive regulation of transporter activityRetinoic acid receptor RXR-alphaHomo sapiens (human)
response to retinoic acidRetinoic acid receptor RXR-alphaHomo sapiens (human)
peroxisome proliferator activated receptor signaling pathwayRetinoic acid receptor RXR-alphaHomo sapiens (human)
mRNA transcription by RNA polymerase IIRetinoic acid receptor RXR-alphaHomo sapiens (human)
steroid hormone mediated signaling pathwayRetinoic acid receptor RXR-alphaHomo sapiens (human)
positive regulation of DNA-templated transcriptionRetinoic acid receptor RXR-alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIRetinoic acid receptor RXR-alphaHomo sapiens (human)
retinoic acid receptor signaling pathwayRetinoic acid receptor RXR-alphaHomo sapiens (human)
positive regulation of vitamin D receptor signaling pathwayRetinoic acid receptor RXR-alphaHomo sapiens (human)
cell differentiationRetinoic acid receptor RXR-alphaHomo sapiens (human)
anatomical structure developmentRetinoic acid receptor RXR-alphaHomo sapiens (human)
cellular response to organic substanceCaspase-1Homo sapiens (human)
pattern recognition receptor signaling pathwayCaspase-1Homo sapiens (human)
proteolysisCaspase-1Homo sapiens (human)
apoptotic processCaspase-1Homo sapiens (human)
signal transductionCaspase-1Homo sapiens (human)
osmosensory signaling pathwayCaspase-1Homo sapiens (human)
protein autoprocessingCaspase-1Homo sapiens (human)
positive regulation of interleukin-1 beta productionCaspase-1Homo sapiens (human)
positive regulation of interleukin-18 productionCaspase-1Homo sapiens (human)
defense response to bacteriumCaspase-1Homo sapiens (human)
regulation of apoptotic processCaspase-1Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionCaspase-1Homo sapiens (human)
positive regulation of cysteine-type endopeptidase activity involved in apoptotic processCaspase-1Homo sapiens (human)
icosanoid biosynthetic processCaspase-1Homo sapiens (human)
regulation of inflammatory responseCaspase-1Homo sapiens (human)
positive regulation of inflammatory responseCaspase-1Homo sapiens (human)
protein maturationCaspase-1Homo sapiens (human)
defense response to virusCaspase-1Homo sapiens (human)
pyroptosisCaspase-1Homo sapiens (human)
cellular response to lipopolysaccharideCaspase-1Homo sapiens (human)
cellular response to mechanical stimulusCaspase-1Homo sapiens (human)
cellular response to type II interferonCaspase-1Homo sapiens (human)
cytokine precursor processingCaspase-1Homo sapiens (human)
signaling receptor ligand precursor processingCaspase-1Homo sapiens (human)
AIM2 inflammasome complex assemblyCaspase-1Homo sapiens (human)
positive regulation of tumor necrosis factor-mediated signaling pathwayCaspase-1Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathwayOxoeicosanoid receptor 1Homo sapiens (human)
G protein-coupled receptor signaling pathwayOxoeicosanoid receptor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (51)

Processvia Protein(s)Taxonomy
G protein-coupled receptor activityFree fatty acid receptor 1Homo sapiens (human)
lipid bindingFree fatty acid receptor 1Homo sapiens (human)
bioactive lipid receptor activityFree fatty acid receptor 1Homo sapiens (human)
peroxidase activityProstaglandin G/H synthase 1 Bos taurus (cattle)
heme bindingProstaglandin G/H synthase 1 Bos taurus (cattle)
metal ion bindingProstaglandin G/H synthase 1 Bos taurus (cattle)
monooxygenase activityCytochrome P450 1A2Homo sapiens (human)
iron ion bindingCytochrome P450 1A2Homo sapiens (human)
protein bindingCytochrome P450 1A2Homo sapiens (human)
electron transfer activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1A2Homo sapiens (human)
enzyme bindingCytochrome P450 1A2Homo sapiens (human)
heme bindingCytochrome P450 1A2Homo sapiens (human)
demethylase activityCytochrome P450 1A2Homo sapiens (human)
caffeine oxidase activityCytochrome P450 1A2Homo sapiens (human)
aromatase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A2Homo sapiens (human)
iron ion bindingAromataseHomo sapiens (human)
steroid hydroxylase activityAromataseHomo sapiens (human)
electron transfer activityAromataseHomo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenAromataseHomo sapiens (human)
oxygen bindingAromataseHomo sapiens (human)
heme bindingAromataseHomo sapiens (human)
aromatase activityAromataseHomo sapiens (human)
vitamin D response element bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
transcription cis-regulatory region bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificRetinoic acid receptor RXR-alphaHomo sapiens (human)
transcription coregulator bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
retinoic acid bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
double-stranded DNA bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
DNA-binding transcription factor activityRetinoic acid receptor RXR-alphaHomo sapiens (human)
nuclear steroid receptor activityRetinoic acid receptor RXR-alphaHomo sapiens (human)
nuclear receptor activityRetinoic acid receptor RXR-alphaHomo sapiens (human)
protein bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
zinc ion bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
enzyme bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
peptide bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
identical protein bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
nuclear vitamin D receptor bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
sequence-specific DNA bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
retinoic acid-responsive element bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
DNA binding domain bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
LBD domain bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
sequence-specific double-stranded DNA bindingRetinoic acid receptor RXR-alphaHomo sapiens (human)
endopeptidase activityCaspase-1Homo sapiens (human)
cysteine-type endopeptidase activityCaspase-1Homo sapiens (human)
protein bindingCaspase-1Homo sapiens (human)
cysteine-type endopeptidase activator activity involved in apoptotic processCaspase-1Homo sapiens (human)
kinase bindingCaspase-1Homo sapiens (human)
cytokine bindingCaspase-1Homo sapiens (human)
identical protein bindingCaspase-1Homo sapiens (human)
CARD domain bindingCaspase-1Homo sapiens (human)
caspase bindingCaspase-1Homo sapiens (human)
G protein-coupled receptor activityOxoeicosanoid receptor 1Homo sapiens (human)
protein bindingOxoeicosanoid receptor 1Homo sapiens (human)
5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid bindingOxoeicosanoid receptor 1Homo sapiens (human)
5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid bindingOxoeicosanoid receptor 1Homo sapiens (human)
5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid bindingOxoeicosanoid receptor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (23)

Processvia Protein(s)Taxonomy
plasma membraneFree fatty acid receptor 1Homo sapiens (human)
plasma membraneFree fatty acid receptor 1Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 1 Bos taurus (cattle)
endoplasmic reticulum membraneCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
endoplasmic reticulumAromataseHomo sapiens (human)
endoplasmic reticulum membraneAromataseHomo sapiens (human)
membraneAromataseHomo sapiens (human)
endoplasmic reticulumAromataseHomo sapiens (human)
nucleusRetinoic acid receptor RXR-alphaHomo sapiens (human)
nucleoplasmRetinoic acid receptor RXR-alphaHomo sapiens (human)
transcription regulator complexRetinoic acid receptor RXR-alphaHomo sapiens (human)
mitochondrionRetinoic acid receptor RXR-alphaHomo sapiens (human)
cytosolRetinoic acid receptor RXR-alphaHomo sapiens (human)
RNA polymerase II transcription regulator complexRetinoic acid receptor RXR-alphaHomo sapiens (human)
chromatinRetinoic acid receptor RXR-alphaHomo sapiens (human)
receptor complexRetinoic acid receptor RXR-alphaHomo sapiens (human)
cytoplasmCaspase-1Homo sapiens (human)
cytosolCaspase-1Homo sapiens (human)
nucleolusCaspase-1Homo sapiens (human)
cytoplasmCaspase-1Homo sapiens (human)
cytosolCaspase-1Homo sapiens (human)
microtubuleCaspase-1Homo sapiens (human)
plasma membraneCaspase-1Homo sapiens (human)
canonical inflammasome complexCaspase-1Homo sapiens (human)
NLRP1 inflammasome complexCaspase-1Homo sapiens (human)
NLRP3 inflammasome complexCaspase-1Homo sapiens (human)
AIM2 inflammasome complexCaspase-1Homo sapiens (human)
protein-containing complexCaspase-1Homo sapiens (human)
IPAF inflammasome complexCaspase-1Homo sapiens (human)
protease inhibitor complexCaspase-1Homo sapiens (human)
plasma membraneOxoeicosanoid receptor 1Homo sapiens (human)
plasma membraneOxoeicosanoid receptor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (128)

Assay IDTitleYearJournalArticle
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1072602Growth inhibition of ER-positive, HER2-positive human MDA-MB-361 cells after 48 hrs by WST-1 assay2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID1574999Antiplasmodial activity against chloroquine-sensitive final late stage of Plasmodium falciparum NF54-Mal8p1.16-GFP-Luc gametocytes after 24 hrs by BacTiter-Glo assay2019Journal of medicinal chemistry, 01-24, Volume: 62, Issue:2
Structure-Activity Relationship Studies and Plasmodium Life Cycle Profiling Identifies Pan-Active N-Aryl-3-trifluoromethyl Pyrido[1,2- a]benzimidazoles Which Are Efficacious in an in Vivo Mouse Model of Malaria.
AID610674Stability in mouse serum at 1 mM incubated for 2 hrs at 27 degC by HPLC2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID610663Growth inhibition of human MDA-MB-231 cells after 48 hrs by WST1 assay2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID396469Inhibition of tube formation in human EAhy926 cells at 50 uM after 24 hrs by phase-contrast microscopy2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
A new antiangiogenic C24 oxylipin from the soft coral Sinularia numerosa.
AID1072584Induction of apoptosis in human MDA-MB-231 cells assessed as viable cells at 1 uM after 48 hrs by annexin V/propidium iodide based flow cytometry (Rvb = 93.2 +/-0.9%)2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID319010Effect on gramicidin channel 13 activity2007Proceedings of the National Academy of Sciences of the United States of America, Jun-05, Volume: 104, Issue:23
Docosahexaenoic acid alters bilayer elastic properties.
AID1350512Induction of apoptosis in human 143B cells at 12.5 by Annexin V-FITC/propidium iodide double staining based flow cytometry relative to control2018Journal of medicinal chemistry, 07-12, Volume: 61, Issue:13
Antitumorigenic Properties of Omega-3 Endocannabinoid Epoxides.
AID1433793Corrector activity at CFTR F508 deletion mutant in primary human BE cells assessed as induction of autophagy by measuring increase in beclin-1 level at 250 uM in presence of cysteamine measured after 24 hrs by immunoblotting2017Journal of medicinal chemistry, 01-12, Volume: 60, Issue:1
Fatty Acid Cysteamine Conjugates as Novel and Potent Autophagy Activators That Enhance the Correction of Misfolded F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR).
AID319013Activity at gramicidin channel 13 assessed as increase in single channel current at 10 uM2007Proceedings of the National Academy of Sciences of the United States of America, Jun-05, Volume: 104, Issue:23
Docosahexaenoic acid alters bilayer elastic properties.
AID323922Antiviral activity against HCV assessed as inhibition of HCV RNA replication in OR6 cells after 72 hrs by luciferase reporter assay2007Antimicrobial agents and chemotherapy, Jun, Volume: 51, Issue:6
Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture.
AID1885198Antagonist activity at full length human Nurr1 expressed in HEK293T cells co-expressing 3xNBRE3-luciferase at 50 uM incubated for 18 hrs by luciferase transactivation assay relative to control2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
Medicinal Chemistry and Chemical Biology of Nurr1 Modulators: An Emerging Strategy in Neurodegeneration.
AID319011Activity at gramicidin channel 13 assessed as increase in single channel current2007Proceedings of the National Academy of Sciences of the United States of America, Jun-05, Volume: 104, Issue:23
Docosahexaenoic acid alters bilayer elastic properties.
AID1509163Displacement of 3[H]retinol from human biotinylated RBP4 after overnight incubation by surface plasmon resonance analysis2019Journal of medicinal chemistry, 06-13, Volume: 62, Issue:11
Design, Synthesis, and Preclinical Efficacy of Novel Nonretinoid Antagonists of Retinol-Binding Protein 4 in the Mouse Model of Hepatic Steatosis.
AID1450034Growth inhibition of HEK293 cells at 20 uM relative to control2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Antiplasmodial β-triketones from the flowers of the Australian tree Angophora woodsiana.
AID1072608Growth inhibition of ER-positive, HER2-negative human MCF7 cells after 48 hrs by WST-1 assay2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID499580Binding affinity to RXRalpha2010Journal of natural products, Aug-27, Volume: 73, Issue:8
Identification of a naturally occurring rexinoid, honokiol, that activates the retinoid X receptor.
AID1350514Induction of apoptosis in human HOS cells at 12.5 by Annexin V-FITC/propidium iodide double staining based flow cytometry relative to control2018Journal of medicinal chemistry, 07-12, Volume: 61, Issue:13
Antitumorigenic Properties of Omega-3 Endocannabinoid Epoxides.
AID319012Activity at gramicidin A negative channel 15 assessed as increase in single channel current2007Proceedings of the National Academy of Sciences of the United States of America, Jun-05, Volume: 104, Issue:23
Docosahexaenoic acid alters bilayer elastic properties.
AID1433794Corrector activity at CFTR F508 deletion mutant in primary human BE cells assessed as induction of autophagy by measuring increase in LC3-2 to LC3-1 ratio at 250 uM measured after 24 hrs in presence of cysteamine by immunoblotting2017Journal of medicinal chemistry, 01-12, Volume: 60, Issue:1
Fatty Acid Cysteamine Conjugates as Novel and Potent Autophagy Activators That Enhance the Correction of Misfolded F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR).
AID1751423Potentiation of fluconazole-induced antifungal activity against Candida albicans SC5314 assessed as inhibition of fungal filamentation by measuring reduction in fungal hyphae growth in YEPD containing 10% serum medium at 100 uM incubated for 1 hr in prese2021Bioorganic & medicinal chemistry, 08-15, Volume: 44Evaluation of artemisinin derivative artemether as a fluconazole potentiator through inhibition of Pdr5.
AID444973Induction of neurite outgrowth in human U87 cells at 40 to 60 uM after 48 hrs by crystal violet staining2009Journal of medicinal chemistry, Dec-10, Volume: 52, Issue:23
Synthesis of new alkylaminooxysterols with potent cell differentiating activities: identification of leads for the treatment of cancer and neurodegenerative diseases.
AID1180602Agonist activity at human RXR-alpha expressed in HEK293 cells coexpressing with pCMX-beta-gal after 24 to 48 hrs by luciferase reporter gene assay2014Journal of natural products, Jul-25, Volume: 77, Issue:7
Rexinoids isolated from Sophora tonkinensis with a gene expression profile distinct from the synthetic rexinoid bexarotene.
AID1450025Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 measured after 72 hrs by DAPI staining based high throughput screening assay2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Antiplasmodial β-triketones from the flowers of the Australian tree Angophora woodsiana.
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1616999Substrate activity at human FAAH expressed in baculovirus infected Sf9 cells assessed as docosahexaenoic acid formation incubated for 60 mins by HPLC analysis2019Journal of medicinal chemistry, 11-14, Volume: 62, Issue:21
Structure-Activity Relationships of Fish Oil Derivatives with Antiallergic Activity in Vitro and in Vivo.
AID243367Activation of PPAR gamma at 5 uM in Cos-7 cell reporter gene assay with 5%FBS2005Bioorganic & medicinal chemistry letters, Feb-01, Volume: 15, Issue:3
Identification of putative metabolites of docosahexaenoic acid as potent PPARgamma agonists and antidiabetic agents.
AID627976Cytotoxicity against human HCT116 cells by WST-1 assay2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID1072592Cell cycle arrest in PR, ER, HER2-negative human MDA-MB-231 cells assessed as accumulation at G2/M phase at 1 uM after 30 hrs by flow cytometer (Rvb = 17.1 +/-2.1%)2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID1072589Cell cycle arrest in PR, ER, HER2-negative human MDA-MB-231 cells assessed as accumulation at G2/M phase at 10 uM after 30 hrs by flow cytometer (Rvb = 17.1 +/-2.1%)2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID1616998Antiallergic activity in BALB/c mouse assessed as reduction in anti-DNP-IgE-mediated passive cutaneous anaphylaxis at 1000 mg/kg, po administered once daily for 5 days followed by anti-DNP-IgE stimulation on day 4 and subsequent DNP-HSA challenge on day 52019Journal of medicinal chemistry, 11-14, Volume: 62, Issue:21
Structure-Activity Relationships of Fish Oil Derivatives with Antiallergic Activity in Vitro and in Vivo.
AID406142Antitumor activity against mouse L1210 cells2008Bioorganic & medicinal chemistry, Jul-01, Volume: 16, Issue:13
Synthesis and antitumor activity evaluations of albumin-binding prodrugs of CC-1065 analog.
AID627980Cytotoxicity against mouse RAW264.7 cells at 5 uM2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID1616996Inhibition of human FAAH expressed in baculovirus infected Sf9 cells using N-(6-methoxypyridin-3-yl)octanamide as substrate measured for 15 mins by fluorescence based assay2019Journal of medicinal chemistry, 11-14, Volume: 62, Issue:21
Structure-Activity Relationships of Fish Oil Derivatives with Antiallergic Activity in Vitro and in Vivo.
AID627875Inhibition of histidine-tagged human DNA polymerase gamma using poly(dA)/oligo(dT)18 (A/T = 2/1) and dTTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID1433795Corrector activity at CFTR F508 deletion mutant in primary human BE cells assessed as induction of autophagy by measuring decrease in p62 level at 250 uM measured after 24 hrs in presence of cysteamine by immunoblotting2017Journal of medicinal chemistry, 01-12, Volume: 60, Issue:1
Fatty Acid Cysteamine Conjugates as Novel and Potent Autophagy Activators That Enhance the Correction of Misfolded F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR).
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1072613Growth inhibition of PR, ER, HER2-negative human MDA-MB-231 cells at <25 uM after 48 hrs by WST-1 assay2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID1885199Antagonist activity at full length human Nurr1 expressed in MN9D cells co-expressing 3xNBRE3-luciferase at 50 uM incubated for 18 hrs by luciferase transactivation assay relative to control2022Journal of medicinal chemistry, 07-28, Volume: 65, Issue:14
Medicinal Chemistry and Chemical Biology of Nurr1 Modulators: An Emerging Strategy in Neurodegeneration.
AID1446793Binding affinity to RXR (unknown origin)2017Journal of medicinal chemistry, 07-13, Volume: 60, Issue:13
Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery.
AID627878Inhibition of histidine-tagged human DNA polymerase gamma using bovine deoxyribonuclease 1-treated DNA and dNTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID610673Stability in human serum at 1 mM incubated for 2 hrs at 27 degC by HPLC2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID1433759Corrector activity at CFTR F508 deletion mutant in primary human BE cells assessed as induction of autophagy by measuring increase in LC3-2 to LC3-1 ratio at 250 uM measured after 24 hrs by immunoblotting2017Journal of medicinal chemistry, 01-12, Volume: 60, Issue:1
Fatty Acid Cysteamine Conjugates as Novel and Potent Autophagy Activators That Enhance the Correction of Misfolded F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR).
AID1751418Potentiation of amphotericin B-induced antifungal activity against Candida albicans SC5314 assessed as fungal growth at 100 microM measured after 24 hrs in presence of amphotericin B by absorbance based analysis relative to amphotericin B-treated control2021Bioorganic & medicinal chemistry, 08-15, Volume: 44Evaluation of artemisinin derivative artemether as a fluconazole potentiator through inhibition of Pdr5.
AID1450026Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum Dd2 measured after 72 hrs by DAPI staining based high throughput screening assay2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Antiplasmodial β-triketones from the flowers of the Australian tree Angophora woodsiana.
AID1615905Displacement of CU-6PMN from human RXRalpha LBD incubated for 2 hrs by fluorescence based assay2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Competitive Binding Assay with an Umbelliferone-Based Fluorescent Rexinoid for Retinoid X Receptor Ligand Screening.
AID627874Inhibition of calf DNA polymerase alpha using poly(dA)/oligo(dT)18 (A/T = 2/1) and dTTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID610661Induction of apoptosis in human MDA-MB-231 cells assessed as viable cells at 1 uM after 24 hrs by annexin V/propidium iodide staining based FACS flow cytometry (Rvb = 89 +/- 1 %)2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID1350513Induction of apoptosis in human MG63 cells at 12.5 by Annexin V-FITC/propidium iodide double staining based flow cytometry relative to control2018Journal of medicinal chemistry, 07-12, Volume: 61, Issue:13
Antitumorigenic Properties of Omega-3 Endocannabinoid Epoxides.
AID1072597Cytotoxicity against human HMEC assessed as growth inhibition after 48 hrs by WST-1 assay2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID1072582Induction of apoptosis in human MDA-MB-231 cells assessed as necrotic cells at 1 uM after 48 hrs by annexin V/propidium iodide based flow cytometry (Rvb = 4.4 +/-0.4%)2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID360929Selectivity ratio for IC50 for sheep COX2 to IC50 for bovine COX22001Journal of natural products, Jun, Volume: 64, Issue:6
Cox-2 inhibitory effects of naturally occurring and modified fatty acids.
AID376618Inhibition of aromatase in human SKBR3 cells at 100 uM relative to control2006Journal of natural products, Apr, Volume: 69, Issue:4
Interference by naturally occurring fatty acids in a noncellular enzyme-based aromatase bioassay.
AID360928Inhibition of bovine COX1-mediated prostaglandin biosynthesis using [1-14C]arachidonic acid2001Journal of natural products, Jun, Volume: 64, Issue:6
Cox-2 inhibitory effects of naturally occurring and modified fatty acids.
AID1313430Agonist activity at GPR40 (unknown origin) by Fluo-4 AM dye based calcium mobilization assay2016ACS medicinal chemistry letters, Jun-09, Volume: 7, Issue:6
Design and Synthesis of 2-Alkylpyrimidine-4,6-diol and 6-Alkylpyridine-2,4-diol as Potent GPR84 Agonists.
AID444970Induction of neurite outgrowth in human SK-N-SH cells at 40 to 60 uM after 48 hrs by crystal violet staining2009Journal of medicinal chemistry, Dec-10, Volume: 52, Issue:23
Synthesis of new alkylaminooxysterols with potent cell differentiating activities: identification of leads for the treatment of cancer and neurodegenerative diseases.
AID1072581Induction of apoptosis in human MDA-MB-231 cells assessed as viable cells at 5 uM after 48 hrs by annexin V/propidium iodide based flow cytometry (Rvb = 93.2 +/-0.9%)2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID1575239Stimulation of human 20S proteasome at 25 uM using 11 amino acid FRET peptide as substrate measured every 2 mins over 1 hr by FRET assay relative to control2019Bioorganic & medicinal chemistry letters, 02-01, Volume: 29, Issue:3
Analysis of chain length, substitution patterns, and unsaturation of AM-404 derivatives as 20S proteasome stimulators.
AID1072593Cell cycle arrest in PR, ER, HER2-negative human MDA-MB-231 cells assessed as accumulation at S phase at 1 uM after 30 hrs by flow cytometer (Rvb = 33.1 +/-0.3%)2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID692593Agonist activity at GPR40 expressed in CHO cells assessed as intrinsic efficacy after 20 seconds by aequorin bioluminescence assay in presence of 0.1 % human serum relative to AM-16382012ACS medicinal chemistry letters, Sep-13, Volume: 3, Issue:9
Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist.
AID627979Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha secretion at 5 uM treated 30 mins before LPS challenge measured after 24 hrs by ELISA2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID1067780Antagonist activity at human OXE receptor fused with G-alphai assessed as inhibition of 5-oxo-ETE-induced GTPgammaS binding after 60 mins by liquid scintillation counting analysis2014Journal of medicinal chemistry, Jan-23, Volume: 57, Issue:2
Inhibition of 5-oxo-6,8,11,14-eicosatetraenoic acid-induced activation of neutrophils and eosinophils by novel indole OXE receptor antagonists.
AID610669Induction of apoptosis in human MDA-MB-231 cells assessed as apoptotic cells at 1 uM after 24 hrs by annexin V/propidium iodide staining based FACS flow cytometry (Rvb = 1.8 +/- 0.3 %)2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID1072577Induction of apoptosis in human MDA-MB-231 cells assessed as apoptotic cells at 10 uM after 48 hrs by annexin V/propidium iodide based flow cytometry (Rvb = 2.4 +/-0.5%)2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID319016Partition coefficient (x10-4) across dioleoylphosphatidylcholine bilayer in presence of cholesterol2007Proceedings of the National Academy of Sciences of the United States of America, Jun-05, Volume: 104, Issue:23
Docosahexaenoic acid alters bilayer elastic properties.
AID627879Inhibition of C-terminal His6-tagged human DNA polymerase kappa (amino acids 1 to 560) using bovine deoxyribonuclease 1-treated DNA and dNTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID1443212Agonist activity at human GPR40 expressed in HEK293T cells transfected with 0.05 ug of GPR40 expression plasmid assessed as increase in intracellular Ca2+ flux by Fluo 4-AM dye based assay2017Journal of medicinal chemistry, 04-13, Volume: 60, Issue:7
Discovery of Potent and Orally Bioavailable GPR40 Full Agonists Bearing Thiophen-2-ylpropanoic Acid Scaffold.
AID610711Inhibition of HDAC in human MDA-MB-231 cells up to 25 uM after 2 hrs relative to control2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID1433760Corrector activity at CFTR F508 deletion mutant in primary human BE cells assessed as induction of autophagy by measuring decrease in p62 level at 250 uM measured after 24 hrs by immunoblotting2017Journal of medicinal chemistry, 01-12, Volume: 60, Issue:1
Fatty Acid Cysteamine Conjugates as Novel and Potent Autophagy Activators That Enhance the Correction of Misfolded F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR).
AID1072579Induction of apoptosis in human MDA-MB-231 cells assessed as necrotic cells at 5 uM after 48 hrs by annexin V/propidium iodide based flow cytometry (Rvb = 4.4 +/-0.4%)2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID1072576Induction of apoptosis in human MDA-MB-231 cells assessed as necrotic cells at 10 uM after 48 hrs by annexin V/propidium iodide based flow cytometry (Rvb = 4.4 +/-0.4%)2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID1072591Cell cycle arrest in PR, ER, HER2-negative human MDA-MB-231 cells assessed as accumulation at G0/G1 phase at 10 uM after 30 hrs by flow cytometer (Rvb = 49.8 +/-1.5%)2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID319014Activity at gramicidin channel 13 assessed as increase in single channel current at 10 uM in presence of cholesterol2007Proceedings of the National Academy of Sciences of the United States of America, Jun-05, Volume: 104, Issue:23
Docosahexaenoic acid alters bilayer elastic properties.
AID376615Inhibition of aromatase in human placental microsomes at 20 ug/ml by radiometric method relative to control2006Journal of natural products, Apr, Volume: 69, Issue:4
Interference by naturally occurring fatty acids in a noncellular enzyme-based aromatase bioassay.
AID1751417Antifungal activity against Candida albicans SC5314 assessed as inhibition of fungal growth by measuring decrease in OD600 at 100 microM measured after 24 hrs by absorbance based analysis2021Bioorganic & medicinal chemistry, 08-15, Volume: 44Evaluation of artemisinin derivative artemether as a fluconazole potentiator through inhibition of Pdr5.
AID444971Induction of neurite outgrowth in human SH-SY5Y cells at 40 to 60 uM after 48 hrs by crystal violet staining2009Journal of medicinal chemistry, Dec-10, Volume: 52, Issue:23
Synthesis of new alkylaminooxysterols with potent cell differentiating activities: identification of leads for the treatment of cancer and neurodegenerative diseases.
AID319015Partition coefficient (x10-4) across dioleoylphosphatidylcholine bilayer2007Proceedings of the National Academy of Sciences of the United States of America, Jun-05, Volume: 104, Issue:23
Docosahexaenoic acid alters bilayer elastic properties.
AID444972Induction of neurite outgrowth in mouse Neuro2a cells at 40 to 60 uM after 48 hrs by crystal violet staining2009Journal of medicinal chemistry, Dec-10, Volume: 52, Issue:23
Synthesis of new alkylaminooxysterols with potent cell differentiating activities: identification of leads for the treatment of cancer and neurodegenerative diseases.
AID1751424Potentiation of fluconazole-induced antifungal activity against Candida albicans SC5314 assessed as inhibition of fungal filamentation by measuring reduction in fungal hyphae growth in Spider medium at 100 uM incubated for 1 hr in presence of fluconazole 2021Bioorganic & medicinal chemistry, 08-15, Volume: 44Evaluation of artemisinin derivative artemether as a fluconazole potentiator through inhibition of Pdr5.
AID1072587Downregulation of p21 expression in human PR, ER, HER2-negative human MDA-MB-231 cells at 10 uM after 24 hrs by western blot analysis2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID610668Induction of apoptosis in human MDA-MB-231 cells assessed as viable cells at 10 uM after 24 hrs by annexin V/propidium iodide staining based FACS flow cytometry (Rvb = 89 +/- 1 %)2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID1744328Displacement of 6-(Ethyl-{5-isobutoxy-4-isopropyl-2-[(10-oxo-2,3,5,6-tetrahydro-1H,4H,10H-11-oxa-3a-aza-benzo[de]anthracene-9-carbonyl)-amino]-phenyl}-amino)-nicotinic acid from human RXRalpha-LBD by by fluorescence binding assay
AID1072583Induction of apoptosis in human MDA-MB-231 cells assessed as apoptotic cells at 1 uM after 48 hrs by annexin V/propidium iodide based flow cytometry (Rvb = 2.4 +/-0.5%)2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID1443214Agonist activity at human GPR40 expressed in HEK293T cells transfected with 5 ug of GPR40 expression plasmid assessed as increase in intracellular Ca2+ flux by Fluo 4-AM dye based assay2017Journal of medicinal chemistry, 04-13, Volume: 60, Issue:7
Discovery of Potent and Orally Bioavailable GPR40 Full Agonists Bearing Thiophen-2-ylpropanoic Acid Scaffold.
AID1072594Cell cycle arrest in PR, ER, HER2-negative human MDA-MB-231 cells assessed as accumulation at G0/G1 phase at 1 uM after 30 hrs by flow cytometer (Rvb = 49.8 +/-1.5%)2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID610672Induction of apoptosis in human MDA-MB-231 cells assessed as necrotic cells at 10 uM after 24 hrs by annexin V/propidium iodide staining based FACS flow cytometry (Rvb = 9.2 +/- 0.8 %)2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID627876Inhibition of C-terminal His6-tagged human DNA polymerase kappa (amino acids 1 to 560) using poly(dA)/oligo(dT)18 (A/T = 2/1) and dTTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID1072606Total growth inhibition of ER-negative, HER2-positive human AU565 cells at >15 uM after 48 hrs by WST-1 assay2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID1751422Antifungal activity against Candida albicans SC5314 assessed as inhibition of fungal filamentation in Spider medium at 100 uM incubated for 1 hr by microscopic analysis2021Bioorganic & medicinal chemistry, 08-15, Volume: 44Evaluation of artemisinin derivative artemether as a fluconazole potentiator through inhibition of Pdr5.
AID610664Growth inhibition of human MDA-MB-231 cells at 25 uM after 48 hrs by WST1 assay2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID1072580Induction of apoptosis in human MDA-MB-231 cells assessed as apoptotic cells at 5 uM after 48 hrs by annexin V/propidium iodide based flow cytometry (Rvb = 2.4 +/-0.5%)2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID1072598Growth inhibition of PR, ER, HER2-negative human MDA-MB-468 cells after 48 hrs by WST-1 assay2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID1751421Antifungal activity against Candida albicans SC5314 assessed as inhibition of fungal filamentation in YEPD containing 10% serum medium at 100 uM incubated for 1 hr by microscopic analysis2021Bioorganic & medicinal chemistry, 08-15, Volume: 44Evaluation of artemisinin derivative artemether as a fluconazole potentiator through inhibition of Pdr5.
AID1433758Corrector activity at CFTR F508 deletion mutant in primary human BE cells assessed as induction of autophagy by measuring increase in beclin-1 level at 250 uM measured after 24 hrs by immunoblotting2017Journal of medicinal chemistry, 01-12, Volume: 60, Issue:1
Fatty Acid Cysteamine Conjugates as Novel and Potent Autophagy Activators That Enhance the Correction of Misfolded F508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR).
AID628060Inhibition of recombinant His-tagged human DNA polymerase lambda using poly(dA)/oligo(dT)18 (A/T = 2/1) and dTTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID627877Inhibition of calf DNA polymerase alpha using bovine deoxyribonuclease 1-treated DNA and dNTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1616997Antiallergic activity in rat RBL2H3 cells assessed as inhibition of DNP-HSA-mediated degranulation by measuring decrease in beta-hexosaminidase activity preincubated for 30 mins followed by DNP-HSA stimulation and measured after 30 mins by 4-nitrophenyl 22019Journal of medicinal chemistry, 11-14, Volume: 62, Issue:21
Structure-Activity Relationships of Fish Oil Derivatives with Antiallergic Activity in Vitro and in Vivo.
AID1072578Induction of apoptosis in human MDA-MB-231 cells assessed as viable cells at 10 uM after 48 hrs by annexin V/propidium iodide based flow cytometry (Rvb = 93.2 +/-0.9%)2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID610670Induction of apoptosis in human MDA-MB-231 cells assessed as apoptotic cells at 10 uM after 24 hrs by annexin V/propidium iodide staining based FACS flow cytometry (Rvb = 1.8 +/- 0.3 %)2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID627982Antiinflammatory activity in mouse assessed as inhibition of TPA-induced mouse ear edema at 500 ug/ear administered 30 mins before TPA challenge measured after 7 hrs relative to untreated control2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID1289642Inhibition of NFkappaB in mouse RAW 264.7 cells at 78.7 uM preincubated for 2 hrs followed by LPS addition for 3 hrs by luciferase reporter gene assay relative to control2016Journal of medicinal chemistry, Feb-11, Volume: 59, Issue:3
Synthesis and Characterization of Fatty Acid Conjugates of Niacin and Salicylic Acid.
AID1072590Cell cycle arrest in PR, ER, HER2-negative human MDA-MB-231 cells assessed as accumulation at S phase at 10 uM after 30 hrs by flow cytometer (Rvb = 33.1 +/-0.3%)2014Bioorganic & medicinal chemistry, Mar-15, Volume: 22, Issue:6
Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
AID360927Inhibition of sheep COX2-mediated prostaglandin biosynthesis using [1-14C]arachidonic acid2001Journal of natural products, Jun, Volume: 64, Issue:6
Cox-2 inhibitory effects of naturally occurring and modified fatty acids.
AID376617Inhibition of aromatase in human placental microsomes by radiometric method2006Journal of natural products, Apr, Volume: 69, Issue:4
Interference by naturally occurring fatty acids in a noncellular enzyme-based aromatase bioassay.
AID627981Cytotoxicity against mouse RAW264.7 cells2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID319017Partition coefficient (x10-4) across dieicosenoyl-phosphatidylcholine bilayer2007Proceedings of the National Academy of Sciences of the United States of America, Jun-05, Volume: 104, Issue:23
Docosahexaenoic acid alters bilayer elastic properties.
AID610671Induction of apoptosis in human MDA-MB-231 cells assessed as necrotic cells at 1 uM after 24 hrs by annexin V/propidium iodide staining based FACS flow cytometry (Rvb = 9.2 +/- 0.8 %)2010Bioorganic & medicinal chemistry, Mar-01, Volume: 18, Issue:5
Characterization of anticancer properties of 2,6-diisopropylphenol-docosahexaenoate and analogues in breast cancer cells.
AID444974Induction of neurite outgrowth in mouse P19 cells at 40 to 60 uM after 48 hrs by crystal violet staining2009Journal of medicinal chemistry, Dec-10, Volume: 52, Issue:23
Synthesis of new alkylaminooxysterols with potent cell differentiating activities: identification of leads for the treatment of cancer and neurodegenerative diseases.
AID627880Inhibition of recombinant His-tagged human DNA polymerase lambda using bovine deoxyribonuclease 1-treated DNA and dNTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins2011Bioorganic & medicinal chemistry, Oct-01, Volume: 19, Issue:19
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
AID692589Agonist activity at GPR40 expressed in CHO cells after 20 seconds by aequorin bioluminescence assay in presence of 0.1 % human serum2012ACS medicinal chemistry letters, Sep-13, Volume: 3, Issue:9
Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID1801388Inhibition Assay from Article 10.1111/cbdd.12572: \\Lazaroids U83836E and U74389G are potent, time-dependent inhibitors of caspase-1.\\2015Chemical biology & drug design, Nov, Volume: 86, Issue:5
Lazaroids U83836E and U74389G are potent, time-dependent inhibitors of caspase-1.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2000The Journal of biological chemistry, Sep-01, Volume: 275, Issue:35
Crystal structure and thermodynamic analysis of human brain fatty acid-binding protein.
AID1811Experimentally measured binding affinity data derived from PDB2000The Journal of biological chemistry, Sep-01, Volume: 275, Issue:35
Crystal structure and thermodynamic analysis of human brain fatty acid-binding protein.
AID1345809Human FFA1 receptor (Free fatty acid receptors)2003The Journal of biological chemistry, Mar-28, Volume: 278, Issue:13
The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids.
AID1346640Rat TRPA1 (Transient Receptor Potential channels)2012PloS one, , Volume: 7, Issue:6
TRPA1 is a polyunsaturated fatty acid sensor in mammals.
AID1346679Human K2P10.1 (Two P domain potassium channels)2000The Journal of biological chemistry, Sep-15, Volume: 275, Issue:37
Human TREK2, a 2P domain mechano-sensitive K+ channel with multiple regulations by polyunsaturated fatty acids, lysophospholipids, and Gs, Gi, and Gq protein-coupled receptors.
AID1345809Human FFA1 receptor (Free fatty acid receptors)2003Nature, Mar-13, Volume: 422, Issue:6928
Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40.
AID1346763Mouse Retinoid X receptor-alpha (2B. Retinoid X receptors)1999Endocrine reviews, Oct, Volume: 20, Issue:5
Peroxisome proliferator-activated receptors: nuclear control of metabolism.
AID1346763Mouse Retinoid X receptor-alpha (2B. Retinoid X receptors)2001Biochimica et biophysica acta, Oct-31, Volume: 1521, Issue:1-3
Phytanic acid and docosahexaenoic acid increase the metabolism of all-trans-retinoic acid and CYP26 gene expression in intestinal cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (48)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (2.08)18.2507
2000's14 (29.17)29.6817
2010's27 (56.25)24.3611
2020's6 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.58 (24.57)
Research Supply Index3.91 (2.92)
Research Growth Index5.16 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.08%)5.53%
Reviews3 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other44 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]